Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma

Journal of Pathology

Volumn 230, Issue 3, 2013, Pages 298-309

  Lee, Chia Huei ^a   Wong, Thian Sze ^b   Chan, Jimmy Yu Wai ^b   Lu, Shao Chun ^c   Lin, Pinpin ^a   Cheng, Ann Joy ^d   Chen, Yin Ju ^d   Chang, Jeffrey Shu Ming ^a   Hsiao, Shu Huei ^e   Leu, Yu Wei ^e   Li, Chuan I ^a   Hsiao, Jenn Ren ^f   Chang, Jang Yang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

BEX1; hypermethylation; LDOC1; male predominance; NF B; risk factor exposure; X linked tumour suppressor gene

Indexed keywords

ACTIN; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE IV; CYSTEINE DIOXYGENASE; CYTOCHROME C OXIDASE; ENDOTHELIN 3; GLUTAMATE RECEPTOR; GROWTH DIFFERENTIATION FACTOR 10; HEMOGLOBIN A2; HEPARAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ ALPHA2; LEUCINE ZIPPER PROTEIN; METALLOTHIONEIN III; MITOCHONDRIAL CREATINE KINASE; NERVE CELL ADHESION MOLECULE; OSTEOGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR D; POTASSIUM CHANNEL; PROENKEPHALIN; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR 3; PROTEIN P50; PROTEIN TYROSINE PHOSPHATASE; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EXPRESSED X LINKED 1 GENE; CANCER INHIBITION; CELL GROWTH; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE INACTIVATION; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LEUCINE ZIPPER DOWN REGULATED IN CANCER 1 GENE; MOLECULAR PATHOLOGY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE; COHORT STUDIES; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, X-LINKED; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MICE; MICE, SCID; MOUTH NEOPLASMS; NERVE TISSUE PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RANDOM ALLOCATION; SEX FACTORS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84878771970     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4173     Document Type: Article

References (44)

1. Su CC, Yang HF, Huang SJ, et al. Distinctive features of oral cancer in Changhua County: high incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habit. J Formos Med Assoc 2007; 106: 225-233.
2. Kingsley K, O'Malley S, Ditmyer M, et al. Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health 2008; 8: 87.
3. Boing AF, Peres MA, Antunes JL,. Mortality from oral and pharyngeal cancer in Brazil: trends and regional patterns, 1979-2002. Rev Panam Salud Publica 2006; 20: 1-8. (Pubitemid 44580281)
4. Ko YC, Huang YL, Lee CH, et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-453.
5. Lee CH, Ko YC, Huang HL, et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 2003; 88: 366-372.
6. Lin WJ, Jiang RS, Wu SH, et al. Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol 2011; 2011: 525976.
7. Wen CP, Tsai SP, Cheng TY, et al. Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan. Tob Control 2005; 14 (suppl 1): i16-22. (Pubitemid 40806899)
8. Christensen BC, Kelsey KT, Zheng S, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 2010; 6: e1001043.
9. Mathers JC, Strathdee G, Relton CL,. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 2010; 71: 3-39.
10. Takeshima M, Saitoh M, Kusano K, et al. High frequency of hypermethylation of p14, p15 and p16 in oral precancerous lesions associated with betel-quid chewing in Sri Lanka. J Oral Pathol Med 2008; 37: 475-479.
11. Tran TN, Liu Y, Takagi M, et al. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. J Oral Pathol Med 2005; 34: 150-156. (Pubitemid 40293223)
12. 6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk. J Oral Pathol Med 2010; 39: 645-650.
13. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428. (Pubitemid 34587077)
14. Chen YK, Huang HC, Lin LM, et al. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999; 35: 173-179. (Pubitemid 29113060)
15. Chiang CT, Hwang YH, Su CC, et al. Elucidating the underlying causes of oral cancer through spatial clustering in high-risk areas of Taiwan with a distinct gender ratio of incidence. Geospat Health 2010; 4: 230-242.
16. Rheinwald JG, Beckett MA,. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981; 41: 1657-1663. (Pubitemid 11114553)
17. Lin SC, Liu CJ, Chiu CP, et al. Establishment of OC3 oral carcinoma cell line and identification of NF-κB activation responses to areca nut extract. J Oral Pathol Med 2004; 33: 79-86.
18. Mori Y, Cai K, Cheng Y, et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and five other genes in colon cancer. Gastroenterology 2006; 131: 797-808. (Pubitemid 44307065)
19. Nagasaki K, Schem C, von Kaisenberg C, et al. Leucine-zipper protein, LDOC1, inhibits NF-κB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 2003; 105: 454-458. (Pubitemid 36578547)
20. Tanaka T, Nakayama H, Yoshitake Y, et al. Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma. Cancer Sci 2012; 103: 455-463.
21. Rehman AO, Wang CY,. CXCL12/SDF-1α activates NF-κB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int J Oral Sci 2009; 1: 105-118.
22. Takamune Y, Ikebe T, Nagano O, et al. Involvement of NF-κB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma. Biochem Biophys Res Commun 2008; 365: 393-398. (Pubitemid 350137302)
23. Sabatino L, Fucci A, Pancione M, et al. UHRF1 coordinates peroxisome proliferator activated receptor-γ (PPARγ) epigenetic silencing and mediates colorectal cancer progression. Oncogene 2012; 31: 5061-5072.
24. Pancione M, Sabatino L, Fucci A, et al,. Epigenetic silencing of peroxisome proliferator-activated receptor-γ is a biomarker for colorectal cancer progression and adverse patients' outcome. PloS One 2010; 5: e14229.
25. Yuan H, Li MY, Ma LT, et al,. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. Thorax 2010; 65: 321-326.
26. Amoruso A, Gunella G, Rondano E, et al,. Tobacco smoke affects expression of peroxisome proliferator-activated receptor-γ in monocyte/macrophages of patients with coronary heart disease. Br J Pharmacol 2009; 158: 1276-1284.
27. Ghosh A, Ghosh S, Maiti GP, et al,. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol 2009; 217: 408-419.
28. Sinha S, Chunder N, Mukherjee N, et al,. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 2008; 15: 1070-1080.
29. Shang C, Guo Y, Fu S, et al,. SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. Med Sci Monit 2010; 16: BR168-173.
30. Maiti GP, Ghosh A, Chatterjee R, et al,. Reduced expression of limd1 in ulcerative oral epithelium associated with tobacco and areca nut. Asian Pac J Cancer Prev 2012; 13: 4341-4346.
31. Salemi M, Castiglione R, La Vignera S, et al,. Over-expression of LDOC1 and PARP1, two pro-apoptotic genes, in a patient with cryptorchidism and DiGeorge anomaly. Hum Cell 2011; 24: 112-113.
32. Inoue M, Takahashi K, Niide O, et al,. LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett 2005; 579: 604-608.
33. Foltz G, Ryu GY, Yoon JG, et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 2006; 66: 6665-6674. (Pubitemid 44085623)
34. Rhodus NL, Ho V, Miller CS, et al. NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 2005; 29: 42-45. (Pubitemid 40283497)
35. Rao SK, Pavicevic Z, Du Z, et al. Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem 2010; 285: 32512-32521.
36. 1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006; 27: 1273-1284.
37. Lin SC, Liu CJ, Yeh WI, et al. Functional polymorphism in NF-κB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 2006; 243: 47-54.
38. Lin CW, Hsieh YS, Hsin CH, et al. Effects of NF-κB1 and NF-κBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One 2012; 7: e35078.
39. Wutz A., Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet 2011; 12: 542-553.
40. Liu Y, Wang L, Zheng P,. X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity. Trends Genet 2010; 26: 260-265.
41. Liu R, Kain M, Wang L,. Inactivation of X-linked tumor suppressor genes in human cancer. Future Oncol 2012; 8: 463-481.
42. Berletch JB, Yang F, Xu J, et al. Genes that escape from X inactivation. Hum Genet 2010; 130: 237-245.
43. Spatz A, Borg C, Feunteun J,. X-chromosome genetics and human cancer. Nat Rev Cancer 2004; 4: 617-629. (Pubitemid 39025056)
44. Ostrer H., Invited review: sex-based differences in gene expression. J Appl Physiol 2001; 91: 2384-2388.